Juergen Siepmann PhD Pharmaceutical Technology
Course and current status
1995-1999: PhD in Pharmaceutical Technology, Freie Univ. Berlin
1999-2001: Post-doc, Univ. of Angers, France
2001-2003: Ass. Prof., Freie Univ. Berlin
Since 2004: Prof., Pharmaceutical Technology, Univ. of Lille, France
Since 2010: Director, INSERM U 1008
Since 2010: President, APGI
Scientific summary
Juergen Siepmann studied pharmacy and did his Ph.D. at the Freie Universitaet Berlin, Germany. Since 2004 he is Professor of Pharmaceutical Technology at the University of Lille, France. His awards include the “APV-Prize for the outstanding doctoral thesis in Pharmaceutical Sciences from the years 1998/99”, a Marie Curie Individual Fellowship and the "2012 APV Research Award for Outstanding Achievements in the Pharmaceutical Sciences". He was visiting scientist/postdoctoral fellow at Purdue University, the University of Paris-Sud, the University of Iowa and the University of Angers.
His research focuses on controlled drug delivery systems, in particular on the elucidation of the underlying mass transport phenomena and the optimization of the devices.
So far, he published his work in more than 120 articles in peer-reviewed, international scientific journals, 200 poster presentations and 90 oral presentations at national and international scientific meetings. He is editor of 3 books and author of 16 book chapters.
Prof. Siepmann is Reviews Editor of “International Journal of Pharmaceutics”, Co-editor of Journal of Drug Delivery Sciences and Technology and member of the editorial boards of “European Journal of Pharmaceutics and Biopharmaceutics”, “European Journal of Pharmaceutical Sciences”, “Drug Development and Industrial Pharmacy”, and “Journal of Controlled Release”.
Since 2010 he serves as president of the APGI (www.apgi.org). Prof. Siepmann is involved in the organization of various scientific meetings; he chaired for instance the 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Malta in 2010 (> 1100 participants).
Since 2010 Prof. Siepmann is heading the INSERM research group “Controlled Drug Delivery Systems and Biomaterials” (about 5 professors, 5 lecturers, 3 technicians, 15 post-docs and PhD students and 10 master students).
